Comprehensive Step-by-Step Guide to Material Status Labelling System in GMP Warehouses

Effective control of raw materials, packaging components, intermediate, and finished products within Good Manufacturing Practice (GMP) warehouses mandates a robust material status labelling system in GMP. This system ensures materials are correctly identified throughout their lifecycle, minimizing risks related to cross-contamination, mix-ups, and use of unapproved or rejected materials. Proper implementation supports compliance with regulatory expectations from FDA, EMA, MHRA and aligns with international guidelines such as PIC/S and WHO GMP. This detailed tutorial outlines the design principles, regulatory requirements, and operational controls necessary to establish a compliant and reliable status labelling system, emphasizing critical labelling categories including quarantine, approved, and rejected materials.

Step 1: Understand the Regulatory Framework and GMP Expectations

The foundation of a compliant material status labelling system in GMP warehouses begins with thorough knowledge of the regulatory environment governing pharmaceutical storage and material handling. Both the US FDA’s 21 CFR Part 211 and the EU GMP guidelines (especially EU GMP Volume 4 – EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use) emphasize the necessity of positive identification and control of materials in warehouses.

Key regulatory points include:

• Material identification: All materials must be uniquely identifiable and labelled to prevent unintended use.
• Status labelling: Materials must carry status labels such as quarantine, approved, or rejected that clearly communicate usability.
• Control of rejected materials: Rejected or returned materials require segregated storage and clear labelling to avoid inadvertent use.
• Traceability and documentation: Status changes must be documented in accordance with batch record and warehouse management procedures.

Furthermore, MHRA and PIC/S guidelines also highlight the need for clear, durable labelling with distinct colour coding or other visual cues to facilitate rapid status recognition during routine warehouse inspections and audits. The labelling system must integrate seamlessly with warehouse management systems and quality assurance procedures ensuring traceable and reliable control at each handling stage. FDA guidance on pharmaceutical manufacturing controls should be consulted for detailed process expectations applicable in the US context.

Step 2: Define Material Status Categories and Visual Identification Requirements

Establishing standardized status labels is critical. The system must categorise all materials into distinct statuses such as quarantine, approved, and rejected. Each category has unique implications and handling instructions. Defining these clearly prevents confusion and supports GMP compliance throughout the warehouse lifecycle.

Quarantine Status

Materials entering the warehouse but not yet released for use must be labelled quarantine. This status applies to raw materials pending quality control testing, packaging components awaiting approval, or products in hold due to incomplete documentation. Quarantine labels must be prominently displayed and designed using a unique colour (commonly yellow or orange) to differentiate from other statuses.

• Purpose: Indicate materials are temporarily withheld from processing or use.
• Visual Requirements: Large, bold “QUARANTINE” text in contrasting colour with expiry or hold reason where applicable.
• Placement: Affixed in multiple locations on the container or pallet to ensure visibility.

Approved Status

Once materials pass all quality checks, including release testing and documentation review, they are assigned approved status. This label confirms that materials are authorized for use in manufacturing. Green is the preferred status label colour, symbolizing acceptance and readiness for use.

• Purpose: Communicate materials are certified and cleared for production.
• Visual Requirements: Clear “APPROVED” text with batch number, expiry dates, and release signature or code.
• Placement: Labels must appear at visible points to support rapid identification and stock rotation.

Rejected Status

Materials that fail testing, are damaged, or otherwise deemed unsuitable must be distinctly labelled rejected. This strict segregation prevents accidental usage and facilitates management of non-conforming supplies. Red coloured labels are commonly used for maximum visual impact.

• Purpose: Identify materials that cannot be used and require disposition actions such as return, reprocessing, or destruction.
• Visual Requirements: Prominent “REJECTED” text, reason for rejection, and date.
• Placement: Labels applied in multiple locations; rejected materials must be stored separately in dedicated areas within the warehouse.

Additional status labels may include returned, reserved, or in process depending on warehouse complexity and organizational procedures. All label designs should be documented within the warehouse’s Quality Management System (QMS) and be validated for durability, legibility, and resistance to environmental factors common in GMP warehouses.

Step 3: Design and Validation of the Status Labelling System

The design phase converts requirements into practical labelling tools and documentation. A carefully designed system allows for easy implementation and reliable long-term operation. Considerations include label material, printing method, colour coding, size, content, and attachment method to containers or storage racks.

Label Material and Durability

Labels must resist common warehouse environments including exposure to moisture, temperature variations, UV light, and handling abrasion. Use materials such as polyester, polypropylene, or vinyl with strong adhesive backing. Labels should not peel, fade, or lose legibility during storage to maintain compliance.

Information Content on Labels

• Status category (e.g., QUARANTINE, APPROVED, REJECTED) in large font size
• Material identification (name, code, batch/lot number)
• Date of issue or status assignment
• Responsible person or department code for status assignment
• Expiry or retest date if applicable

Where feasible, implement barcodes or QR codes linking to Warehouse Management System (WMS) entries for electronic tracking and audit trail creation. This integration supports compliance with data integrity principles.

Colour Coding and Visual Design

Adopt a consistent colour scheme validated through human factors assessment for clarity and avoidance of confusion in high-volume warehouses. Position approved, quarantine, and rejected label colours on a visible spectrum, with green, yellow, and red being the industry norm.

Label Attachment and Location

Labels must be affixed to multiple surfaces such as container tops and sides, pallet stretch film, or storage locations to guarantee visibility during routine stock handling, inventory management, and production picking. Avoid obstructing other critical container information including expiry date or handling instructions.

Validation and Documentation

The labelling system, including label materials, print methods, and workflows, must be qualified by documented validation protocols. Tests should include:

• Adhesion tests under warehouse conditions
• Readability after environmental exposure
• Verification of label accuracy against batch records
• Durability during transport and handling

Validation reports and approved label templates form part of the regulated documents maintained under EMA GMP compliance requirements. Periodic review of the labelling system ensures ongoing suitability, incorporating feedback from quality audits and warehouse inspections.

Step 4: Implementing Procedures and Controls for Labelling Accuracy

Implementation extends beyond label production to include comprehensive administrative and operational controls. These reduce human errors and enforce consistent application of status labels.

Development of Standard Operating Procedures (SOPs)

Create detailed SOPs describing:

• Criteria for labelling each status category
• Instructions on applying, removing, and replacing status labels
• Responsibilities for label issuance and review
• Process for updating status following quality release or rejection decisions
• Handling of mixed or partially used containers with multiple statuses

The SOPs must be incorporated into training programs for warehouse, QA, and QC personnel. Employees must be qualified to perform labelling activities and periodically re-trained, ensuring full comprehension and compliance.

Control of Label Inventory and Printing

Maintain secure and controlled stock of pre-printed status labels. Label printing must be authorized and performed either electronically via validated systems or manually under strict supervision. Any defects or label discrepancies must be reported and investigated.

Label Application Verification

Apply a dual-check system where one employee applies the status label and a second verifies accuracy against batch status and documentation. This verification step can be manual or supplemented by automated scanning, contributing to reduced risk of errors.

Procedures for Status Change and Relabelling

When material status changes — for example, quarantine to approved after release testing — the previous status labels must be removed or clearly marked invalid, and new approved labels applied immediately. Failure to update labels promptly can lead to use of unapproved materials, constituting a serious GMP breach.

Segregation and Storage Controls

Materials must be physically segregated according to their status to reinforce the visual labelling system and prevent mix-ups. Quarantine materials are stored separately from approved stock, with rejected materials isolated logically and access restricted until disposition. These practices should be documented in warehouse layout plans and verified during GMP inspections.

Step 5: Audit, Review, and Continuous Improvement of the Labelling System

Ongoing oversight and continual improvement are essential to maintain an effective material status labelling system in GMP. Robust internal audits and periodic management reviews help identify deficiencies and opportunities for enhanced risk control.

Internal and External Audits

Audit teams should evaluate label use compliance, SOP adherence, label condition, and segregation practices during regular GMP audits and readiness inspections. Checklist items include label legibility, correct status coding, timely labelling changes, and training effectiveness.

Investigations of Deviations and Nonconformities

Any discrepancy involving material status labelling—such as incorrect labels applied, missing labels, or mixed-status storage—must trigger a formal investigation. Root cause analysis should examine procedural weaknesses or training gaps, followed by corrective and preventive actions documentation.

Performance Metrics and KPIs

Define key performance indicators such as:

• Percentage of materials correctly labelled on first inspection
• Number of labelling errors detected
• Turnaround time for status changes and label updates

Tracking these metrics enables data-driven adjustments improving system reliability and GMP compliance.

System Updates and Technology Integration

Pharmaceutical warehouses should evaluate opportunities to implement technology-driven labelling solutions such as RFID tags or automated barcode scanning integrated with Warehouse Management Systems. Such tools enhance data integrity, reduce manual errors, and support regulatory compliance aligned with ICH Q10 Quality System principles.

Periodic review also includes revising label design, SOP updates, and personnel retraining in response to regulatory changes or internal findings.

Conclusion

Implementing a fully controlled material status labelling system in GMP warehouses safeguards product quality and patient safety by enforcing unambiguous material identification throughout storage and handling. By following the step-by-step guide above—grounded in regulatory expectations and industry best practices—pharmaceutical companies can create a robust, audit-ready labelling system employing clear quarantine, approved, and rejected status labels. Meticulous design, comprehensive procedures, thorough validation, and continuous improvement ensure the system remains effective, resilient, and compliant within US, UK, and EU regulatory frameworks.